These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 33692752)

  • 1. Endocrinology of the Aging Prostate: Current Concepts.
    Cannarella R; Condorelli RA; Barbagallo F; La Vignera S; Calogero AE
    Front Endocrinol (Lausanne); 2021; 12():554078. PubMed ID: 33692752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign Prostatic Hyperplasia, Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: Is Metaflammation the Link?
    Russo GI; Cimino S; Castelli T; Favilla V; Gacci M; Carini M; Condorelli RA; La Vignera S; Calogero AE; Motta F; Puzzo L; Caltabiano R; Morgia G
    Prostate; 2016 Dec; 76(16):1528-1535. PubMed ID: 27458062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign prostatic hyperplasia: a new metabolic disease?
    Vignozzi L; Rastrelli G; Corona G; Gacci M; Forti G; Maggi M
    J Endocrinol Invest; 2014 Apr; 37(4):313-22. PubMed ID: 24458832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Link between circadian rhythm and benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS).
    Cavanaugh D; Urbanucci A; Mohamed NE; Tewari AK; Figueiro M; Kyprianou N
    Prostate; 2024 Apr; 84(5):417-425. PubMed ID: 38193363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Breyer BN; Huang WY; Rabkin CS; Alderete JF; Pakpahan R; Beason TS; Kenfield SA; Mabie J; Ragard L; Wolin KY; Grubb RL; Andriole GL; Sutcliffe S
    BJU Int; 2016 Jan; 117(1):145-54. PubMed ID: 25601300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.
    Nickel JC; Elhilali M; Vallancien G;
    BJU Int; 2005 Mar; 95(4):571-4. PubMed ID: 15705082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Prostate Size Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from the REDUCE Trial.
    Simon RM; Howard LE; Moreira DM; Roehrborn C; Vidal AC; Castro-Santamaria R; Freedland SJ
    Eur Urol; 2016 May; 69(5):885-91. PubMed ID: 26724841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of inflammation in lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) and its potential impact on medical therapy.
    Ficarra V; Rossanese M; Zazzara M; Giannarini G; Abbinante M; Bartoletti R; Mirone V; Scaglione F
    Curr Urol Rep; 2014 Dec; 15(12):463. PubMed ID: 25312251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome-related factors as possible targets for lower urinary tract symptoms in Korean males.
    Heo JE; Kim DG; Yoo JW; Lee KS
    Aging Male; 2023 Dec; 26(1):6-12. PubMed ID: 36633207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The underlying mechanism of metabolic syndrome on benign prostatic hyperplasia and prostate volume.
    Xia BW; Zhao SC; Chen ZP; Chen C; Liu TS; Yang F; Yan Y
    Prostate; 2020 May; 80(6):481-490. PubMed ID: 32104919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Status of the Relationship Between Metabolic Syndrome and Lower Urinary Tract Symptoms.
    Sebastianelli A; Gacci M
    Eur Urol Focus; 2018 Jan; 4(1):25-27. PubMed ID: 29602736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rural vs. urban disparities in association with lower urinary tract symptoms and benign prostatic hyperplasia in ageing men, NHANES 2001-2008.
    Egan KB; Suh M; Rosen RC; Burnett AL; Ni X; Wong DG; McVary KT
    Int J Clin Pract; 2015 Nov; 69(11):1316-25. PubMed ID: 26215544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone and Benign Prostatic Hyperplasia.
    Rastrelli G; Vignozzi L; Corona G; Maggi M
    Sex Med Rev; 2019 Apr; 7(2):259-271. PubMed ID: 30803920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARĪ³: a molecular link between systemic metabolic disease and benign prostate hyperplasia.
    Jiang M; Strand DW; Franco OE; Clark PE; Hayward SW
    Differentiation; 2011; 82(4-5):220-36. PubMed ID: 21645960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Relationship between Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms and Mean Platelet Volume: The Role of Metabolic Syndrome.
    Zhao S; Tang J; Shao S; Yan Y
    Urol Int; 2016; 96(4):449-58. PubMed ID: 26745140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and heritability of benign prostatic hyperplasia and LUTS in men aged 40 years or older in Zhengzhou rural areas.
    Yue L; Wang T; Ge Y; Ge M; Zhang C; Hou Q; Wang W; Tian H; Ren B; Du B; Zhang W
    Prostate; 2019 Feb; 79(3):312-319. PubMed ID: 30450670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms: Prevalence and Incident Rates.
    Egan KB
    Urol Clin North Am; 2016 Aug; 43(3):289-97. PubMed ID: 27476122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Circadian Syndrome Predicts Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia Better Than Metabolic Syndrome in Aging Males: A 4-Year Follow-Up Study.
    Xiong Y; Zhang F; Wu C; Zhang Y; Huang X; Qin F; Yuan J
    Front Med (Lausanne); 2021; 8():715830. PubMed ID: 34621761
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship between Metabolic Syndrome and Predictors for Clinical Benign Prostatic Hyperplasia Progression and International Prostate Symptom Score in Patients with Moderate to Severe Lower Urinary Tract Symptoms.
    Zhao S; Chen C; Chen Z; Xia M; Tang J; Shao S; Yan Y
    Urol J; 2016 Jun; 13(3):2717-26. PubMed ID: 27351328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PDE5 inhibitors blunt inflammation in human BPH: a potential mechanism of action for PDE5 inhibitors in LUTS.
    Vignozzi L; Gacci M; Cellai I; Morelli A; Maneschi E; Comeglio P; Santi R; Filippi S; Sebastianelli A; Nesi G; Serni S; Carini M; Maggi M
    Prostate; 2013 Sep; 73(13):1391-402. PubMed ID: 23765639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.